Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasmsH I Scher, A Sarkis, V Reuter, et al.
Urology|August 1, 1996
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapyG L Wright, B M Grob, C Haley, et al.
Cancer|August 1, 1984
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamideT Ahmed, P Benedetto, A Yagoda, et al.
The Journal of Clinical Investigation|October 1, 1988
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urotheliumJ L Gabrilove, A Jakubowski, K Fain, et al.
Annals of Internal Medicine|April 1, 1988
Advanced seminoma: the role of chemotherapy and adjunctive surgeryR J Motzer, G J Bosl, N L Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumorsG J Bosl, N L Geller, D Bajorin, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesionH I Scher, A Yagoda, H W Herr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumorsC N Sternberg, A Yagoda, N H Bander, et al.
The Journal of Urology|March 1, 1985
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Cancer|December 15, 1989
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseC N Sternberg, A Yagoda, H I Scher, et al.
Pageof 10